10-101062803-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001319303.2(KAZALD1):c.-259A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,577,584 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 20 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 33 hom. )
Consequence
KAZALD1
NM_001319303.2 5_prime_UTR_premature_start_codon_gain
NM_001319303.2 5_prime_UTR_premature_start_codon_gain
Scores
2
16
Clinical Significance
Conservation
PhyloP100: -0.252
Genes affected
KAZALD1 (HGNC:25460): (Kazal type serine peptidase inhibitor domain 1) This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0037122667).
BP6
Variant 10-101062803-A-T is Benign according to our data. Variant chr10-101062803-A-T is described in ClinVar as [Benign]. Clinvar id is 716217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00921 (1402/152290) while in subpopulation AFR AF= 0.0327 (1358/41564). AF 95% confidence interval is 0.0312. There are 20 homozygotes in gnomad4. There are 641 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAZALD1 | NM_030929.5 | c.211A>T | p.Arg71Trp | missense_variant | 2/5 | ENST00000370200.6 | NP_112191.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAZALD1 | ENST00000370200.6 | c.211A>T | p.Arg71Trp | missense_variant | 2/5 | 1 | NM_030929.5 | ENSP00000359219.6 | ||
KAZALD1 | ENST00000470106.1 | n.44-183A>T | intron_variant | 3 | ||||||
KAZALD1 | ENST00000477979.5 | n.112+688A>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00913 AC: 1390AN: 152172Hom.: 19 Cov.: 33
GnomAD3 genomes
AF:
AC:
1390
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00211 AC: 433AN: 205554Hom.: 5 AF XY: 0.00157 AC XY: 181AN XY: 115278
GnomAD3 exomes
AF:
AC:
433
AN:
205554
Hom.:
AF XY:
AC XY:
181
AN XY:
115278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000959 AC: 1367AN: 1425294Hom.: 33 Cov.: 33 AF XY: 0.000821 AC XY: 581AN XY: 707850
GnomAD4 exome
AF:
AC:
1367
AN:
1425294
Hom.:
Cov.:
33
AF XY:
AC XY:
581
AN XY:
707850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00921 AC: 1402AN: 152290Hom.: 20 Cov.: 33 AF XY: 0.00861 AC XY: 641AN XY: 74474
GnomAD4 genome
AF:
AC:
1402
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
641
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
104
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
305
Asia WGS
AF:
AC:
9
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at